Editor's Choice - Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-analysis of Phase III Trials

Details 詳細情報について

• CRID

  1362825893970703872

• DOI

  10.1016/j.ejvs.2014.05.001

• ISSN

  10785884

• Web Site

  https://api.elsevier.com/content/article/PII:S1078588414002482?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S1078588414002482?httpAccept=text/plain

• Data Source

  • Crossref